A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The aim of this paper is to determine the efficacy of dexamphetamine in adult attention deficit hyperactivity disorder (ADHD) in a naturalistic setting. METHOD: A randomised, double-blind, placebo-controlled study of dexamphetamine was conducted by two psychiatrists in private practice who saw a total of 68 consecutive referrals of patients thought to have ADHD by their referring general practitioners. Patients were admitted to the study if their current level of ADHD symptoms satisfied DSM-IV criteria (modified for use in adults), and were not currently comorbid for major mood disturbance or substance abuse. Response to medication was assessed by repeated administration of these modified DSM-IV criteria, self- and relatives' rating, as well as clinician rating using the Clinical Global Impressions Scale. More general outcome measures included the Brief Symptom Inventory and a patient satisfaction questionnaire. Medication side effects were recorded, including monitoring blood pressure and weight change. Urinalysis monitored concurrent substance usage and compliance. RESULTS: Dexamphetamine had a significant therapeutic response exceeding the placebo response (p = 0.045). The response was similar in both genders and across the age range. It was detected by patients, their relatives and the two clinicians. The only significant side effect was weight loss. One patient on dexamphetamine discontinued the trial because of an event possibly related to the medication. CONCLUSIONS: In the short term, dexamphetamine appears to be efficacious in treating adult ADHD. As this is the first study in the literature, the result requires replication. Given that stimulant medication use in adult ADHD appears to be long-term, studies of long-term efficacy need to be carried out.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preliminary Normative Data on DSM-IV Attention Deficit Hyperactivity Disorder in College Students
Heiligenstein, E., Conyers, L. M., Berns, A. R., & Smith, M. A. (1998) · Journal of American College Health · doi:10.1080/07448489809595609 · Cited by 209 · cited 1×
“It is argued that the DSM-IV criteria are too restrictive as the symptom wording reflects childhood behaviour, symptom patterns change over time, and self-report rates (more common with adult studies) are lower than relatives’ reports [11,12].”
Result
Cited by
Diagnostic Controversies in Adult Attention Deficit Hyperactivity Disorder
McGough, J. J., & Barkley, R. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1948 · Cited by 388
Faraone, S. V., & Glatt, S. J. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04902pur · Cited by 387
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261
Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259
“Similar but more limited findings are reported for dexamfetamine (dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al.,…”
ResultAgonist-like, replacement pharmacotherapy for stimulant abuse and dependence
Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.018 · Cited by 257
Metadata
- Authors
- Paterson, R., Douglas, C., Hallmayer, J., Hagan, M., & Krupenia, Z.
- Venue
- Australian and New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 1999-08-26
- Volume
- 33
- Issue
- 4
- Pages
- 494-502
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2022058738
- Cited by
- 80
- References
- 1
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. https://app.cochat.ai/papers/10.1046/j.1440-1614.1999.00590.x
- The paper
- Paterson, R., Douglas, C., Hallmayer, J., Hagan, M., & Krupenia, Z. (1999). A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry. https://doi.org/10.1046/j.1440-1614.1999.00590.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.